The molecular industrial revolution: automated synthesis of small molecules
Recent BMI and comorbidity labs
(13) applied multiple techniques, including region-specific injections of GLP-1R antagonists, lesioning specific nerves and nuclei, ex vivo electrophysiological studies, and peripheral administration of a fluorescently labeled liraglutide molecule in rats, WT mice, and Glp1r / mice to dissect mechanisms that link peripheral administration of a GLP-1R agonist to reduced food intake and weight loss
Posadas I, Santos P, Blanco A, Muoz-Fernndez M, Cea V
Regul Pept 156:8389 Balenovic D, Barisic I, Prkacin I et al (2012) Mortal furosemide-hypokalemia-disturbances in rats NO-system related
Researchers randomly assigned 751 adults with obesity (but without type 2 diabetes) to receive either tirzepatide or semaglutide once a week by injection for 72 weeks that's about 17 months